SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

The community is actively discussing Zebec Network's potential as a long-term utility play, with many investors citing the upcoming Clarity Act and various institutional partnerships as catalysts for growth. Despite recent price volatility, supporters are viewing the dips as accumulation opportunities while others remain skeptical, fueling an ongoing debate about the project's true market value and future trajectory.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor is trending as market participants increasingly view it as a leading infrastructure project for decentralized AI, with significant community excitement surrounding institutional interest, ETF filings, and its role as a "Bitcoin of AI." While some investors voice concerns over subnet volatility and governance centralization, many are using recent price dips as accumulation opportunities, focusing on the long-term utility of its decentralized intelligence network.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as investors react to the company's recent authorization of a multi-billion dollar share repurchase program following strong free cash flow and a quarterly earnings beat. Community sentiment remains focused on the strategic impact of the North American IPO, long-term gold and copper production potential, and the broader debate surrounding the stock's valuation versus historical resistance levels.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as investors debate its role in the real-world asset (RWA) sector, balancing enthusiasm for high-profile institutional partnerships against concerns over price stagnation and long-term tokenomics. The community is actively discussing the potential for a fee switch to generate direct yield for holders while closely monitoring its technical price action amid broader crypto market volatility.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Dominos is drawing significant investor attention as market participants weigh its recent earnings report, which highlighted positive domestic sales growth alongside broader industry concerns over consumer discretionary spending. The community is actively debating the stock's long-term value and competitive positioning, with many retail traders focusing on its potential for a turnaround after recent price fluctuations.

Investment Managers Series Trust II - Tradr 2X Short IREN Daily ETF

Tradr 2X Short IREN Daily ETF

Tradr 2X Short IREN Daily ETF (IREZ) is generating intense trading activity as investors leverage the volatility of IREN to play potential AI sector corrections. The community is actively debating the merits of using these leveraged inverse instruments for short-term gains versus the long-term risk of price decay, with many traders sharing technical strategies, exit points, and cautionary tales about holding positions overnight.

SPDR Series Trust - State Street SPDR S&P Oil & Gas Exploration & Production ETF

SPDR Oil & Gas Exploration & Production ETF

The SPDR Oil & Gas Exploration & Production ETF (XOP) is experiencing significant volatility as investors weigh persistent Middle East geopolitical risks against an uncertain outlook for global oil supply and production quotas. Market participants are actively debating whether current price action represents a sustainable trend or a series of headline-driven bull traps, with many traders focusing on the interplay between OPEC+ production decisions and the impact of broader tariff policies on demand.

RTX Corp. is an aerospace and defense company, which engages in the provision of aerospace and defense systems and services for commercial, military, and government customers. It operates through the following segments: Collins Aerospace Systems (Collins), Pratt and Whitney, Raytheon Intelligence and Space (RIS), and Raytheon Missiles and Defense (RMD). The Collins segment manufactures and sells aero structures, avionics, interiors, mechanical systems, mission systems, and power controls. The Pratt and Whitney segment includes the design and manufacture of aircraft engines and auxiliary power systems for commercial, military, and business aircraft. The RIS segment is involved in the development of sensors, training, and cyber and software solutions. The RMD segment offers end-to-end solutions to detect, track, and engage threats. The company was founded in 1922 and is headquartered in Arlington, VA.

RTX Corp

Raytheon Technologies Corporation

RTX is trending as institutional investors focus on its critical role in multi-year defense rearmament cycles, bolstered by significant new missile production contracts and increased US defense budget priorities. Community discussion centers on the company's resilient backlog and the long-term structural demand for precision-guided munitions amidst ongoing geopolitical instability.

Blacksky Technology, Inc. is a space-based intelligence company, which engages in the business of delivering real-time imagery, analytics, and high-frequency monitoring of most critical and strategic locations, economic assets, and events. The firm is also involved in providing geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operation of satellite and ground systems to government and commercial customers. The company was founded in 2014 and is headquartered in Herndon, VA.

BlackSky Technology Inc - Ordinary Shares - Class A

BlackSky Technology is gaining significant momentum as investors rotate into space-based geospatial intelligence and defense-linked infrastructure. The community is actively discussing the stock's strong contract backlog, recent multi-million dollar defense wins, and its potential as a strategic acquisition target within the expanding space economy.

Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The firm investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Unicycive Therapeutics Inc

Unicycive Therapeutics is trending as investors digest news of a securities class action lawsuit alongside ongoing concerns regarding dilution and the timeline for resubmitting its NDA following a previous manufacturing-related rejection. Despite these headwinds, the community remains divided, with some traders actively accumulating shares based on the long-term potential of its hyperphosphatemia treatment, while others remain skeptical of management's communication and the potential for further share price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kura Oncology (KURA) Reports Q1 Loss, Tops Revenue Estimates

Kura Oncology (KURA) delivered earnings and revenue surprises of +5.33% and +21.30%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates

Celldex (CLDX) delivered earnings and revenue surprises of -6.88% and -98.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Will MeiraGTx Holdings PLC (MGTX) Report Negative Q1 Earnings? What You Should Know

MeiraGTx (MGTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Kura Oncology (KURA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kura Oncology (KURA) Projected to Post Quarterly Earnings on Thursday

Kura Oncology (NASDAQ:KURA) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-kura-oncology-inc-stock...

Moody Aldrich Partners LLC Buys New Position in Kura Oncology, Inc. $KURA

Moody Aldrich Partners LLC bought a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 179,728 shares of the company's s...

KURA Stock Rallies 8% on Strong Preliminary Renal Cancer Study Data

Kura Oncology shares jump 8% as FIT-001 data show strong tumor response and disease control with darlifarnib combination in pretreated renal cancer patients.

Kura Oncology (KURA) Moves 8.3% Higher: Will This Strength Last?

Kura Oncology (KURA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Kura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of "Moderate Buy" by Brokerages

Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has received an average recommendation of "Moderate Buy" from the thirteen brokerages that are currently covering the stock, MarketBeat reports...

Kura Oncology (NASDAQ:KURA) Stock Price Up 9.7% - Time to Buy?

Kura Oncology (NASDAQ:KURA) Trading Up 9.7% - Here's What Happened...

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Current Price	$8.74
Prev Close	$8.77
Open	$8.76
Dividend Yield	0.00%
50-Day Moving Average	$9.20
Beta	1.15
Avg. Volume	1.93M
PE Ratio	-2.61

52-Week High	$12.49
52-Week Low	$5.45
Market Capitalization	$775.89M
EPS (Annual)	-$3.18
Price to Book	7.19
Revenue Per Employee	$259,546.15

KURAKura Oncology Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KURA News